INTUITIVE SURGICAL INCISRG

Market cap
$203.8B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income--------1,1251,3821,0671,7281,3441,8172,338
Depreciation and Gain (Loss) on Disposition of Property Plant Equipment-----657486109160226283338402445
Amortization of intangible assets171823212224181314435027282017
Gain on sale of business------------4-1
(Gain) loss on investments and (accretion) amortization of investment discounts and premiums, net---33-37-34-26-36-21-2655-11-49-743
Deferred income taxes---3935-5-19-63-328-5863185281135
Share-based compensation expense118136153169169168178209261336395449513593677
Capitalized Contract Cost, Amortization--------11131722273338
Accounts receivable425169-6914793682161-39-614215918696
Inventory2925770271147116279361170256547713830
Prepaids and other assets-193756811292978117112205129-24232
Accounts payable8108-918-1116141712-32362142-0
Accrued compensation and employee benefits142021-33212219312657-17115523599
Deferred revenue27283115208205354361533225331
Other liabilities--------37123751122-33108
Net cash provided by operating activities5286788148806657721,0431,1441,1701,5981,4852,0891,4911,8142,415
Purchases of investments1,3851,5321,8341,4441,3451,8272,5861,9952,5823,3464,2936,4521,4002,2075,140
Proceeds from sales of investments-----------8561230100
Proceeds from maturities of investments--8008227158269707031,5342,5702,9314,2683,2542,6902,879
Purchase of property, plant, and equipment968314210510681541911874263423545321,0641,111
Payments to Acquire Businesses, Net of Cash Acquired--------88603891391
Net cash provided by (used in) investing activities-476-479-846259-154-849-1,279379-1,050-1,154-941-2,4611,371-360-3,273
Proceeds from Stock Plans141261263161284361581416237273309277234296429
Taxes paid related to net share settlement of equity awards-----112457120159175212194165270
Repurchase of common stock1993322381,1091,000184432,274-270134-2,607416-
Cash dividends paid by joint venture to noncontrolling interest--------------8
Payment of deferred purchase consideration---------238522531
Net cash provided by (used in) financing activities8-12119-911-692193559-1,913126-168-8643-2,572-288151
Effect of exchange rate changes on cash, cash equivalents, and restricted cash------------53-1
Net increase (decrease) in cash, cash equivalents, and restricted cash---------273456-3322951,169-708